Literature DB >> 34866843

Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Grading of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Comparison With Ultrasonography and Magnetic Resonance Spectroscopy.

Nikhil Makhija1, Naval K Vikram2, Deep N Srivastava1, Kumble S Madhusudhan1.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is becoming the most common cause of cirrhosis. Although magnetic resonance spectroscopy (MRS) is considered the gold standard, it has a few limitations. The role of diffusion-weighted imaging (DWI), which is a simpler sequence, in the diagnosis and grading of fatty liver is not well studied. The aim of the study was to investigate the value of DWI in the diagnosis and grading of hepatic steatosis in patients with NAFLD.
MATERIALS AND METHODS: Fifty-one adults (mean age: 38 years; 28 men, 23 women) with NAFLD, diagnosed clinically and by ultrasonography (USG), were included in the study after obtaining informed consent and approval from the institute ethics committee. USG was performed for grading of hepatic steatosis in all patients, followed by magnetic resonance imaging with DWI and MRS, on a 1.5T scanner. The mean apparent diffusion coefficient (ADC) values and proton density fat fraction (PDFF) were calculated, and MRS was used as the gold standard. The mean ADC values were compared with the PDFF and USG grades.
RESULTS: There was a weak correlation between ADC values and PDFF (r = -0.36; P < 0.05). In addition, there was a weak correlation between the ADC values of the liver and USG grade (r = -0.34; P < 0.05). However, an overall increase in USG grades and PDFF was associated with decrease in the mean ADC value (P < 0.001).
CONCLUSION: DWI is not accurate in the diagnosis and grading of hepatic steatosis in patients with NAFLD. However, a significant increase in fat deposition in the liver lowers the ADC values.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADC, Apparent Diffusion Coefficient; DWI, Diffusion-Weighted Imaging; HCC, Hepatocellular Carcinoma; MR spectroscopy; MRI, Magnetic Resonance Imaging; MRS, Magnetic Resonance Spectroscopy; NAFLD, Nonalcoholic Fatty Liver Disease; NASH, Nonalcoholic Steatohepatitis; PDFF, Proton Density Fat Fraction; USG, Ultrasonography; diffusion-weighted imaging; fatty liver; magnetic resonance imaging; nonalcoholic fatty liver disease

Year:  2021        PMID: 34866843      PMCID: PMC8617527          DOI: 10.1016/j.jceh.2021.02.008

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  28 in total

1.  In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging.

Authors:  Moti Freiman; Stephan D Voss; Robert V Mulkern; Jeannette M Perez-Rossello; Michael J Callahan; Simon K Warfield
Journal:  Med Phys       Date:  2012-08       Impact factor: 4.071

Review 2.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

3.  Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults.

Authors:  Paul Murphy; Jonathan Hooker; Brandon Ang; Tanya Wolfson; Anthony Gamst; Mark Bydder; Michael Middleton; Michael Peterson; Cynthia Behling; Rohit Loomba; Claude Sirlin
Journal:  J Magn Reson Imaging       Date:  2014-09-25       Impact factor: 4.813

Review 4.  Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.

Authors:  Cyrielle Caussy; Scott B Reeder; Claude B Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

5.  Diffusion-weighted imaging in the characterization of focal liver lesions: efficacy of visual assessment.

Authors:  Bilal Battal; Murat Kocaoglu; Veysel Akgun; Ibrahim Karademir; Salih Deveci; Inanc Guvenc; Nail Bulakbasi
Journal:  J Comput Assist Tomogr       Date:  2011 May-Jun       Impact factor: 1.826

6.  The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.

Authors:  Stephen A Harrison; Sigurd Torgerson; Paul H Hayashi
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

7.  Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease.

Authors:  Helena S Leitão; Sabrina Doblas; Philippe Garteiser; Gaspard d'Assignies; Valérie Paradis; Feryel Mouri; Carlos F G C Geraldes; Maxime Ronot; Bernard E Van Beers
Journal:  Radiology       Date:  2016-10-27       Impact factor: 11.105

8.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

Authors:  Harald Kramer; Perry J Pickhardt; Mark A Kliewer; Diego Hernando; Guang-Hong Chen; James A Zagzebski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

9.  Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.

Authors:  Kumaresan Sandrasegaran; Fatih M Akisik; Chen Lin; Bilal Tahir; Janaki Rajan; Romil Saxena; Alex M Aisen
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

Review 10.  Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

Authors:  Mariana V Machado; Helena Cortez-Pinto
Journal:  J Hepatol       Date:  2012-11-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.